Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple organ failure syndrome.

F B Cerra1

  • 1University of Minnesota, Minneapolis.

Disease-A-Month : DM
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Tissue injury triggers systemic responses like shock and inflammation, potentially leading to organ failure. Newer therapies aim to modulate inflammation and improve patient recovery and rehabilitation outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a bioartificial liver employing xenogeneic hepatocytes.

Cytotechnology·2012
Same author

Development of a bioartificial liver device.

Methods in molecular medicine·2011
Same author

Entrapment of hepatocyte spheroids in a hollow fiber bioreactor as a potential bioartificial liver.

Tissue engineering·2009
Same author

Near-infrared and nuclear magnetic resonance spectroscopic assessment of tissue energetics in an isolated, perfused canine hind limb model of dysoxia.

Shock (Augusta, Ga.)·2001
Same author

Modulation of macrophage and B cell function by glycosaminoglycans.

Journal of leukocyte biology·1999
Same author

Enhanced cytochrome P450 IA1 activity of self-assembled rat hepatocyte spheroids.

Cell transplantation·1999
Same journal

Disturbances due to cold.

Disease-a-month : DM·2026
Same journal

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026
Same journal

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026
Same journal

Periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
Same journal

Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

Disease-a-month : DM·2026
Same journal

Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026
See all related articles

Area of Science:

  • Physiology
  • Pathology
  • Critical Care Medicine

Background:

  • Tissue injury from various causes initiates complex local and systemic responses.
  • Systemic responses include shock, inflammation, and organ dysfunction, which can be fatal or lead to prolonged recovery.

Purpose of the Study:

  • To review the pathogenesis and current/emerging treatments for systemic responses to tissue injury.
  • To highlight the role of inflammation and genetic metabolic regulation in injury progression.
  • To emphasize the importance of rehabilitation in patient recovery.

Main Methods:

  • Literature review of physiological and therapeutic responses to tissue injury.
  • Analysis of current treatment strategies focusing on resuscitation and nutrition.

Related Experiment Videos

  • Exploration of novel therapeutic approaches targeting inflammatory modulation and genetic factors.

    • Main Results:

    • Systemic inflammatory response is a key contributor to multiple organ failure and death.
    • Current therapies focus on removing injury cause, microcirculation resuscitation, and nutrition.
    • Emerging therapies aim to modulate inflammation and address genetic metabolic regulation.

    Conclusions:

    • Effective management of tissue injury requires addressing systemic responses, including inflammation.
    • Novel therapies hold promise for minimizing injury potential and promoting recovery.
    • Planned rehabilitation is crucial for long-term patient outcomes in critical care.